• Aucun résultat trouvé

Rebuttal: Should medical journals carry pharmaceutical advertising?: YES

N/A
N/A
Protected

Academic year: 2022

Partager "Rebuttal: Should medical journals carry pharmaceutical advertising?: YES"

Copied!
1
0
0

Texte intégral

(1)

Debates

Web exclusive

Vol 56: october • octobre 2010 Canadian Family PhysicianLe Médecin de famille canadien

e357

D

r Hoey believes advertisements for pharmaceutical products, which, by definition, focus on the advan- tages of one brand name product to the exclusion of all others, undercut the impartial educational mandate of our journal. I suggest, on the other hand, that our read- ers know the difference between advertisements and articles and that there is no possible room for confusion.

He suggests that advertisements for pharmaceuti- cal products are not evidence-based. I note that the products advertised in medical journals must first be approved by Health Canada in a process that is lengthy, extraordinarily rigorous, and entirely evidence-based;

and that the advertisements for those products must be approved by another set of highly professional reviewers at the Pharmaceutical Advertising Advisory Board.

But then Dr Hoey makes rather a leap of pure faith—

from telling us what he thinks to telling us what we think. “Readers,” he writes, “will surely accept my posi- tion” as to why “medical associations like [the College of Family Physicians of Canada] accept pharmaceutical advertising.”

Not necessarily. We at Canadian Family Physician (CFP), for example, don’t so much “accept” advertising as do our very best to sell as much of it as we possibly can. Those advertisements that we succeed in persuad- ing advertisers to place with us are welcomed gratefully and enthusiastically, because every page of advertising we print pays for a page of clinical practice or critical appraisal or commentary or family medicine research.

There is really nothing “distasteful” or “lesser of evils” or

“dismal” about it. When we reach an advertising-sales milestone, we order pizza for the whole journal group to celebrate.

Finally, Dr Hoey advises us that “abandoning the print journal would be a good place to start.” The way I see it, though, the print edition comes to you every month as a surprise package of things you don’t already know, prepared for you by our editors; the electronic media are where you go to look for things when you know what you’re looking for. There is a lot of overlap, of course, but readers should ideally have access to both.

As it happens, CFP did a reader survey this past June and asked a question about usage of the various media in which we provide our journal. A surprising 87% of readers read the print edition, and 53% read only the print edition, while 47% use a combination of print, Web, and digital editions. Abandoning print would mean abandoning most of our readers!

We at CFP certainly don’t want to abandon any read- ers and we continue to believe that advertisements that meet all of the strict requirements for inclusion in medi- cal journals are quite a reasonable way to help pay for producing the journal.

Mr Dehaas is the Publisher of Canadian Family Physician.

competing interests None declared correspondence

David Dehaas, College of Family Physicians of Canada, Publications, 2630 Skymark Ave, Mississauga, ON L4W 5A4; telephone 905 629-0900, extension 316; e-mail ddehaas@cfpc.ca

Mr Dehaas is the Publisher of Canadian Family Physician. The views presented here are his own and do not necessarily reflect those of the College of Family Physicians of Canada.

YES

David Dehaas

Rebuttal: Should medical journals carry pharmaceutical advertising?

Cet article se trouve aussi en français à la page e359.

These rebuttals are responses from the authors of the debates in the October issue (Can Fam Physician 2010;56:978-81 [Eng], 982-5[Fr]).

Références

Documents relatifs

Canadian physicians have a terrific range of choices in medical publications: peer-reviewed journals such as Canadian Family Physician and CMAJ; about 2 dozen spe-

• The revenue from pharmaceutical advertising comes to journals like Canadian Family Physician via increased costs of drugs for patients (and via health insurance companies

My colleague in this debate could have made the case that pharmaceutical advertising directed at physicians is vetted by government agencies (the Pharmaceutical

Dr Lussier is an Associate Professor in the Department of Family Medicine and Emergency Medicine at the University of Montreal in Quebec and a member of the Cité-de-la-santé

As with all health profession- als, when the patient’s situation or condition is beyond their independent scope of practice, they consult with the appropriate health

Therefore, balanced information to patients through advertising can promote appropriate use of drugs, with concomitant benefits to the health care

1-4   These  include  low- ering  the  risks  of  human  papillomavirus,  penile  cancer,  cervical  cancer  in  female  sexual  partners, 

D r Aaron has accurately outlined the beneficial effects  of  β-agonist  use  on  lung  function  in  patients  with  chronic  obstructive  pulmonary